NSC23759
Title:
NSC23759;
.delta.1-Dehydrotestolactone;
.delta.1-Dehydrotestololactone;
.delta.1-Testololactone;
.DELTA.1-Dehydrotestolactone;
.DELTA.1-Dehydrotestololactone;
.DELTA.1-Testololactone;
D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione (9CI);
Delta-1-testololactone;
Fludestrin;
NSC 12173;
NSC-12173;
SQ 9538;
Teolit;
Teslac;
Teslak;
Testolacton;
Testolactone(USAN);
Testololactone, 1-dehydro-;
Testololactone, 1,2-didehydro-;
1-Dehydrotestololactone;
1,2-Dehydrotestololactone;
1, 2-Didehydrotestololactone;
13-Hydroxy-3-oxo-13,17-secoandrosta-1, 4-dien-17-oic acid .delta.-lactone;
13,17-Secoandrosta-1, 4-dien-17-oic acid, 13.alpha.-hydroxy-3-oxo-, .delta.-lactone;
13, 17-Secoandrosta-1,4-dien-17-oic acid, 13-hydroxy-3-oxo-, .delta.-lactone (8CI);
13,17-Secoandrosta-1,4-dien-17-oic acid, 13-hydroxy-3-oxo-, lactone;
13,17-Secoandrosta-1,4-dien-17-oic acid, 13-hydroxy-3-oxo-, .delta.-lactone (8CI);
13, 17-Secoandrosta-1,4-dien-17-oic acid, 13-hydroxy-3-oxo-, lactone;
17a-Oxa-D-homoandrosta-1,4-diene-3,17-dione;
2H-Phenanthro[2, 1-b]pyran-2,8(4bH)-dione, 3,4,4a,5,6,10a,10b,11,12, 12a-decahydro-10a,12a-dimethyl-, lactone
US National Cancer Institute
Show full item record